Publikace
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | 1. lékařská fakulta, 2. lékařská fakulta
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | 2. lékařská fakulta
- Trial Watch: Adoptive cell transfer for oncological indications2015 | 2. lékařská fakulta
- Flt3 ligand expands CD4+FoxP3+regulatory T cells in human subjects2013 | 2. lékařská fakulta
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy2013 | 2. lékařská fakulta
- Type I interferon and cancer2024 | 2. lékařská fakulta
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | 1. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Plzni
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | 1. lékařská fakulta, 2. lékařská fakulta
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | 2. lékařská fakulta
- Interferon signaling restrains renal cell carcinoma heterogeneity2023 | 2. lékařská fakulta
Loading network view...